Ginkgo Bioworks Holdings Inc (MEX:DNA)
MXN 173.2 0 (0%) Market Cap: 8.89 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 0.50 GF Score: 26/100

Q4 2021 Ginkgo Bioworks Holdings Inc Earnings Presentation Transcript

Mar 28, 2022 / 08:30PM GMT

Mar 28, 2022 / 08:30PM GMT
Presentation
Mar 28, 2022 / 08:30PM GMT

=====================
Corporate Participants
=====================
* Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development
* Jason Kelly
Ginkgo Bioworks Holdings, Inc. - Co-Founder, CEO & Director
* Mark E. Dmytruk
Ginkgo Bioworks Holdings, Inc. - CFO

=====================
Conference Call Participants
=====================
* Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
* Mark Anthony Massaro
BTIG, LLC, Research Division - MD & Life Science & Diagnostic Tools Analyst
* Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
* Matthew Richard Larew
William Blair & Company L.L.C., Research Division - Research Analyst
* Poon Mah
Cowen and Company, LLC, Research Division - Senior Analyst
* Rahul Sarugaser
Raymond James Ltd., Research Division - MD and Equity Analyst of Healthcare, Biotechnology & Cannabis

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot